4//SEC Filing
SHALLCROSS STEVEN A 4
Accession 0001104659-23-018901
CIK 0000894158other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 6:06 AM ET
Size
5.6 KB
Accession
0001104659-23-018901
Insider Transaction Report
Form 4
SHALLCROSS STEVEN A
DirectorCEO and CFO
Transactions
- Purchase
Common Stock
2023-02-10$1.04/sh+25,000$26,075→ 210,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $1.02 through $1.05, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Documents
Issuer
Theriva Biologics, Inc.
CIK 0000894158
Entity typeother
Related Parties
1- filerCIK 0001263501
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 6:06 AM ET
- Size
- 5.6 KB